Fairmount Partners

Fairmount Partners is pleased to announce our latest Industrial & Consumer transaction: S. H. Bell Company, a provider of cargo handling services to a diverse customer base in the upper Ohio River Valley, Chicago, and Baltimore regions, was acquired by Associated Terminals. The Fairmount team supporting this transaction was Jonathan Smith, Bill Frame, Mihir Patel, and Brandon Johnson. Learn more here: https://lnkd.in/eXr664uZ

Join Fairmount Partners Managing Director Jonathan Smith and Director Bill Frame for the Delaware Valley Industrial Resource Center (DVIRC) Annual Manufacturing Executives Conference. Fairmount is an advocate of the region’s strong manufacturing base and is thrilled to partner with the DVIRC to bring together leading manufacturing CEOs for a wonderful day of education, networking, and, of course, golf. Register now: https://lnkd.in/ggvMUCfr

Fairmount Partners is pleased to announce our latest Industrial & Consumer transaction: Ballymore Safety Products, a leading designer and manufacturer of highly engineered material handling and vertical access safety products that facilitate the movement of people and goods throughout warehouses, factories, last-mile delivery, and retail locations, was acquired by One Equity Partners. Fairmount originally advised Ballymore in its sale to Graycliff Partners in 2021; with the sale, Graycliff fully exited the business after a successful three-year investment period. The Fairmount team supporting this transaction was Jonathan Smith, Bill Frame, David Peslak, Ryan Remely, and Ian Moore. Learn more here: https://lnkd.in/eVeVJixn

Fairmount Partners’ Industrial & Consumer Practice Director, Bill Frame, will be attending MODEX 2024. Reach out to Bill directly to schedule a meeting: william.frame@fairmountpartners.com.   Register now: https://lnkd.in/gF4h3bEy

Fairmount Partners is pleased to announce that we have advised Kistler O'Brien Fire Protection on its sale to an industry-leading strategic acquirer. As the company embarks on its next phase of growth, KOB’s established leadership team, in concert with new ownership, will continue to drive the expansion of the company’s services offerings, financial and operational scale, and geographic footprint – all with the aim of serving its customers at an elevated level, with additional resources. The Fairmount team supporting this transaction was Jonathan Smith, Bill Frame, and Ryan Remely. Learn more here: https://lnkd.in/eVcrMQF6

Fairmount Partners Managing Director Andrew Brown shared his expert insights on staffing industry M&A with Staffing Industry Analysts. Read the article here: https://lnkd.in/gTUMksuC   For more thoughts on what to expect in the evolving market, contact Andy directly at andrew.brown@fairmountpartners.com.

Fairmount Partners is pleased to announce our latest Industrial & Consumer transaction: Nixon Medical has acquired the medical business of A Linen Connection. A Linen Connection, a provider of laundry services for both medical and food & beverage end markets, has served customers across Central Florida for over 40 years. The acquisition comes as part of Nixon Medical’s next phase of growth. In December 2023, Nixon Medical opened its first healthcare laundry facility in the state of Florida. The Fairmount team supporting this transaction was Jonathan Smith, Bill Frame, and Matt Wittig. Learn more here: https://lnkd.in/e9m4M8zV

We are pleased to present the CDMO Sector – Fairmount Partners 2023 Year in Review. In this review, we look back at notable news, scientific developments, and investments in the CDMO industry, all pointing to a stronger 2024 (and beyond) environment for M&A. Excitement around innovations in cell and gene therapy drug technologies and products, novel therapeutics involving oligos & peptides, and of course, advancements in artificial intelligence, are elevating demand for investments. Fairmount’s industry-leading pharma services group has a transaction portfolio of 180+ deals in 23 countries across North and South America, Australia, Asia and Europe. Within the CDMO and laboratory testing services sectors, we have closed 50+ deals for large services providers, small and mid-sized niche challengers, entrepreneurs and private equity. If you would like to receive a copy, please email cecilia.gleason@fairmountpartners.com.

Fairmount Partners is pleased to present our Pharma Commercialization 2023 Year in Review. In this annual review, we look back at exciting developments and notable transactions in the space, all while gearing up for a fast and furious 2024. We completed 4 Commercialization transactions in 2023, spanning healthcare marketing, medical communications, market access and related services. This gave us invaluable real-time insights into buyer activity and key market trends. We expect deal activity – both volumes and size – to ramp up in 2024, all within a record-high valuation environment. If you would like to receive a copy, please email R.C. Wainwright (richard.wainwright@fairmountpartners.com).

Thrilled to help these two great teams to come together - congrats and best regards for the future together!